Literature DB >> 35412151

Downbeat nystagmus becomes attenuated during walking compared to standing.

Roman Schniepp1, Max Wuehr2, Haike Dietrich1, Cauchy Pradhan1, Felix Heidger1.   

Abstract

Downbeat nystagmus (DBN) is a common form of acquired fixation nystagmus related to vestibulo-cerebellar impairments and associated with impaired vision and postural imbalance. DBN intensity becomes modulated by various factors such as gaze direction, head position, daytime, and resting conditions. Further evidence suggests that locomotion attenuates postural symptoms in DBN. Here, we examined whether walking might analogously influence ocular-motor deficits in DBN. Gaze stabilization mechanisms and nystagmus frequency were examined in 10 patients with DBN and 10 age-matched healthy controls with visual fixation during standing vs. walking on a motorized treadmill. Despite their central ocular-motor deficits, linear and angular gaze stabilization in the vertical plane were functional during walking in DBN patients and comparable to controls. Notably, nystagmus frequency in patients was considerably reduced during walking compared to standing (p < 0.001). The frequency of remaining nystagmus during walking was further modulated in a manner that depended on the specific phase of the gait cycle (p = 0.015). These attenuating effects on nystagmus intensity during walking suggest that ocular-motor control disturbances are selectively suppressed during locomotion in DBN. This suppression is potentially mediated by locomotor efference copies that have been shown to selectively govern gaze stabilization during stereotyped locomotion in animal models.
© 2022. The Author(s).

Entities:  

Keywords:  Downbeat nystagmus; Gaze stabilization; Locomotion; Motor efference copy

Year:  2022        PMID: 35412151     DOI: 10.1007/s00415-022-11106-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  1 in total

1.  Downbeat nystagmus: characteristics and localization of lesions.

Authors:  R D Yee
Journal:  Trans Am Ophthalmol Soc       Date:  1989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.